These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9281234)

  • 21. [Timely commencement of insulin in type 2 diabetes: benefits and risks].
    Winkler G
    Orv Hetil; 2014 Feb; 155(7):255-61. PubMed ID: 24509354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Significance of insulin analogues in the treatment of people with type 2 diabetes].
    Gallwitz B; Westrup D; Schmeisl GW
    Dtsch Med Wochenschr; 2014 Oct; 139(43):2199-203. PubMed ID: 25317651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of miglitol as an add-on to bolus insulin on postprandial glycemic excursions in type 2 diabetes patients assessed by continuous glucose monitoring.
    Matsuura K; Mori Y; Nakamura A; Yokoyama J; Utsunomiya K
    Diabetes Technol Ther; 2012 May; 14(5):423-9. PubMed ID: 22316114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge].
    Ratzmann KP; Schimke E
    Med Klin (Munich); 1995 Oct; 90(10):557-61. PubMed ID: 7500918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HbA(1c) targets for type 2 diabetes: how many, …how far!
    Giugliano D; Ceriello A; Esposito K
    Diabetes Res Clin Pract; 2012 Jun; 96(3):414-5. PubMed ID: 21963106
    [No Abstract]   [Full Text] [Related]  

  • 26. Design and methods of a randomised double-blind trial of adding liraglutide to control HbA1c in patients with type 2 diabetes with impaired glycaemic control treated with multiple daily insulin injections (MDI-Liraglutide trial).
    Lind M; Hirsch IB; Tuomilehto J; Dahlqvist S; Torffvit O; Pehrsson NG
    Prim Care Diabetes; 2015 Feb; 9(1):15-22. PubMed ID: 25175385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
    Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
    Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Step-wise drug therapy in type 2 diabetes mellitus].
    König K; Schatz H
    Z Arztl Fortbild Qualitatssich; 1998 Sep; 92(7):467-73. PubMed ID: 9842691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [When tablets are no longer enough. Which insulin for type 2 diabetic patients?].
    MMW Fortschr Med; 2002 Sep; 144(38):58. PubMed ID: 12395711
    [No Abstract]   [Full Text] [Related]  

  • 30. [Long-acting insulins in the treatment of type 2 diabetes: a hard choice].
    Liebl A
    MMW Fortschr Med; 2015 Apr; 157(7):65-8. PubMed ID: 26012462
    [No Abstract]   [Full Text] [Related]  

  • 31. [Intensive insulin therapy in type 2 diabetes mellitus].
    Jermendy G
    Orv Hetil; 2012 Sep; 153(38):1487-93. PubMed ID: 22985663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Düsseldorf Study.
    Mühlhauser I; Bruckner I; Berger M; Cheţa D; Jörgens V; Ionescu-Tîrgovişte C; Scholz V; Mincu I
    Diabetologia; 1987 Sep; 30(9):681-90. PubMed ID: 3123298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Six-month multicentric, open-label, randomized trial of twice-daily injections of biphasic insulin aspart 30 versus multiple daily injections of insulin aspart in Japanese type 2 diabetic patients (JDDM 11).
    Hirao K; Arai K; Yamauchi M; Takagi H; Kobayashi M;
    Diabetes Res Clin Pract; 2008 Jan; 79(1):171-6. PubMed ID: 17919762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial).
    Lind M; Hirsch IB; Tuomilehto J; Dahlqvist S; Ahrén B; Torffvit O; Attvall S; Ekelund M; Filipsson K; Tengmark BO; Sjöberg S; Pehrsson NG
    BMJ; 2015 Oct; 351():h5364. PubMed ID: 26512041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of a basal-plus insulin regimen in persons with type 2 diabetes stratified by age and body mass index: A pooled analysis of four clinical trials.
    Lankisch MR; Del Prato S; Dain MP; Mullins P; Owens DR
    Prim Care Diabetes; 2016 Feb; 10(1):51-9. PubMed ID: 26150328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intensified insulin therapy. Is there an alternative to BE count?].
    MMW Fortschr Med; 2006 Sep; 148(37):21. PubMed ID: 17036898
    [No Abstract]   [Full Text] [Related]  

  • 37. A simple therapeutic combination for type 2 diabetes.
    Yki-Järvinen H
    Hosp Pract (1995); 2000 Jul; 35(7):63-6, 72-4. PubMed ID: 10916505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose rosiglitazone in patients with type 2 diabetes mellitus requiring insulin therapy.
    Lopez CA; Kanna B
    Arch Intern Med; 2008 Mar; 168(5):548. PubMed ID: 18332304
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.